Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was CNY 5,845.621 million compared to CNY 6,655.063 million a year ago. Operating income was CNY 287.403 million compared to CNY 345.004 million a year ago. Net income was CNY 173.521 million compared to CNY 236.301 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.15 a year ago.